Document is current

Any future updates will be listed below

Therapievorteile mit partiellen Dopamin-D2-Rezeptoragonisten

Crossref DOI link: https://doi.org/10.1007/s15005-018-2844-y

Published Online: 2018-12-17

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark